Elevance Health revenue and financials

ELV · NYSE · USD

$394.51Change from previous close: +2.09%Absolute change: +$8.08

Close · October 5, 2026

In the fiscal year ended December 2025, Elevance Health reported revenue of $199.13B (+12.49% year over year). Net income was $5.66B, a net margin of 2.8%.

Annual revenue · 2025: $199.13B
  1. $84.86B2016
  2. $90.04B2017
  3. $92.11B2018
  4. $104.21B2019
  5. $121.87B2020
  6. $138.64B2021
  7. $156.6B2022
  8. $171.34B2023
  9. $177.01B2024
  10. $199.13B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+12.49%
2025 vs 2024
Net income growth
−5.32%
2025 vs 2024
Net margin
2.8%
2024: 3.4%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue199,125177,011171,340156,595138,639121,867104,21392,10590,04084,863
Cost of revenue21,17819,75017,29313,03510,8958,9531,9920.00.0—
Selling, general and administrative———17,68615,914—————
Operating income7,1997,8628,4998,4527,4896,3605,9995,4264,1754,801
EBIT8,2979,8639,8898,4629,027—————
EBITDA9,04010,52210,9499,5389,844—————
Interest expense1,4031,1851,030851798784746753739723
Pre-tax income6,7107,9047,7157,6007,995—————
Income tax1,0491,9331,7241,7501,8301,6661,1781,3181212,085
Net income5,6625,9805,9876,0256,1044,5724,8073,7503,8432,470
Net income to common shareholders5,6625,9805,9875,8946,158—————
Basic EPS25.2825.8125.3825.1025.0418.2318.8114.5314.709.39
Diluted EPS25.2125.6825.2224.8124.7317.9818.4714.1914.359.21
Average shares (basic)224232236240244—————
Average shares (diluted)225233237243247254260264268268
Dividend per share6.846.525.925.124.52—————